AHCO Stock Analysis
AH
Uncovered
Adapthealth Corp is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Market cap $B
1.427
Dividend yield
—
Shares outstanding
135.45 B
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 10,900 full-time employees. The company went IPO on 2018-02-21. The firm is focused on providing sleep therapy equipment, supplies and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps); home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The breadth of the Company’s product is particularly valuable to acute care hospitals, sleep laboratories and long-term care facilities that discharge patients with complex conditions and multiple product needs.